News

News

25 Jun 2026

Nebu~flow selected for Innovate UK Scaleup Programme

News

25 Jun 2026

Nebu~flow selected for Innovate UK Scaleup Programme

News

25 Jun 2026

Nebu~flow selected for Innovate UK Scaleup Programme

News

25 Jun 2026

Nebu~flow selected for Innovate UK Scaleup Programme

News

3 Jun 2026

Nebu~flow secures £2m Scottish Enterprise grant

News

3 Jun 2026

Nebu~flow secures £2m Scottish Enterprise grant

News

3 Jun 2026

Nebu~flow secures £2m Scottish Enterprise grant

News

3 Jun 2026

Nebu~flow secures £2m Scottish Enterprise grant

News

29 Apr 2026

Biologics promise precision; their delivery often doesn’t

News

29 Apr 2026

Biologics promise precision; their delivery often doesn’t

News

29 Apr 2026

Biologics promise precision; their delivery often doesn’t

News

29 Apr 2026

Biologics promise precision; their delivery often doesn’t

News

10 Oct 2024

Winner of Start-up initiatives award CPHI Pharma 2024

News

10 Oct 2024

Winner of Start-up initiatives award CPHI Pharma 2024

News

10 Oct 2024

Winner of Start-up initiatives award CPHI Pharma 2024

News

10 Oct 2024

Winner of Start-up initiatives award CPHI Pharma 2024

Team

11 Sept 2024

Nebu~Flow welcomes Andrea Cusack as Chief Executive Officer

Andrea Cusack CEO of Nebuflow

Team

11 Sept 2024

Nebu~Flow welcomes Andrea Cusack as Chief Executive Officer

Andrea Cusack CEO of Nebuflow

Team

11 Sept 2024

Nebu~Flow welcomes Andrea Cusack as Chief Executive Officer

Andrea Cusack CEO of Nebuflow

Team

11 Sept 2024

Nebu~Flow welcomes Andrea Cusack as Chief Executive Officer

Andrea Cusack CEO of Nebuflow

Investment

29 Apr 2024

Nebu-Flow secures £4.7m to accelerate next generation respiratory pharmaceuticals

Dr Elijah Nazarzadeh (CEO) and Dr John Pritchard (Chair) of Nebu-Flow

Investment

29 Apr 2024

Nebu-Flow secures £4.7m to accelerate next generation respiratory pharmaceuticals

Dr Elijah Nazarzadeh (CEO) and Dr John Pritchard (Chair) of Nebu-Flow

Investment

29 Apr 2024

Nebu-Flow secures £4.7m to accelerate next generation respiratory pharmaceuticals

Dr Elijah Nazarzadeh (CEO) and Dr John Pritchard (Chair) of Nebu-Flow

Investment

29 Apr 2024

Nebu-Flow secures £4.7m to accelerate next generation respiratory pharmaceuticals

Dr Elijah Nazarzadeh (CEO) and Dr John Pritchard (Chair) of Nebu-Flow

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449

Sign up for our latest news and updates

By signing up you agree to our privacy policy.

© 2026 Acu-Flow Limited (trading as Nebu-Flow®) Registered number: SC624449